United Services Automobile Association Macrogenics Inc Transaction History

United Services Automobile Association

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$12.44 - $17.48 $724,256 - $1.02 Million	-58,220 Closed	0 $0
Q2 2019 Aug 16, 2019	SELL	$14.51 - $19.71 $30,166 - $40,977	-2,079 Reduced 3.45%	58,220 $988,000
Q1 2019 May 13, 2019	SELL	$11.11 - $25.6 $76,659 - $176,640	-6,900 Reduced 10.27%	60,299 $1.08 Million
Q4 2018 Feb 13, 2019	SELL	$11.75 - $21.42 $37,600 - $68,544	-3,200 Reduced 4.55%	67,199 $853,000
Q2 2018 Sep 27, 2018	SELL	$19.78 - $24.67 $15.4 Million - $19.2 Million	-779,582 Reduced 91.72%	70,399 $1.45 Million
Q2 2018 Aug 10, 2018	BUY	$19.78 - $24.67 $15.4 Million - $19.2 Million	779,582 Added 1107.38%	849,981 $90.3 Million
Q1 2018 May 14, 2018	BUY	$18.89 - $32.46 $649,797 - $1.12 Million	34,399 Added 95.55%	70,399 $1.77 Million
Q4 2017 Feb 14, 2018	BUY	$16.19 - $20.3 $582,840 - $730,800	36,000	36,000 $684,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.